Co-Authors
This is a "connection" page, showing publications co-authored by Jonathan Grinstein and Mark Belkin.
Connection Strength
9.832
-
Reviving the Swan: Presenting the Chicago Hemodynamic Forum. Circ Heart Fail. 2025 Apr; 18(4):e012725.
Score: 0.988
-
Standardization of the Right Heart Catheterization and the Emerging Role of Advanced Hemodynamics in Heart Failure. J Card Fail. 2023 11; 29(11):1543-1555.
Score: 0.886
-
Should We Be Using Aortic Pulsatility Index Over Cardiac Power Output in Heart Failure Cardiogenic Shock? Circ Heart Fail. 2022 07; 15(7):e009601.
Score: 0.815
-
Physiology and Clinical Utility of HeartMate Pump Parameters. J Card Fail. 2022 05; 28(5):845-862.
Score: 0.791
-
Improved Prognostic Performance of Cardiac Power Output With Right Atrial Pressure: A Subanalysis of the ESCAPE Trial. J Card Fail. 2022 05; 28(5):866-869.
Score: 0.783
-
Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure. J Card Fail. 2021 10; 27(10):1045-1052.
Score: 0.758
-
Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial. ESC Heart Fail. 2021 04; 8(2):1522-1530.
Score: 0.745
-
Left Ventricular Assist Device Performance Under Pressure: Troubleshooting Outflow Graft Dysfunction. Circ Heart Fail. 2020 07; 13(7):e007098.
Score: 0.713
-
Massive Myocardial Calcium Deposition: Hardened Heart. JACC Case Rep. 2020 Jun 17; 2(7):996-1003.
Score: 0.711
-
Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study. J Card Fail. 2025 Feb 13.
Score: 0.245
-
Dynamic assessment of left ventricular coupling and myocardial reserve in patients with cardiogenic shock. Eur Heart J Open. 2024 Sep; 4(5):oeae072.
Score: 0.238
-
Galectin-3 as a Prognostic Biomarker of Left Ventricular Assist Device Implantation Outcomes. ASAIO J. 2025 Feb 01; 71(2):136-142.
Score: 0.236
-
Pulse Pressure Response to Inotrope Therapy in Cardiogenic Shock: A Subanalysis of the DOREMI Trial. JACC Heart Fail. 2024 Jun; 12(6):1126-1127.
Score: 0.234
-
New-Onset Neurosarcoidosis Following Heart Transplant for Cardiac Sarcoidosis. JACC Case Rep. 2024 Jun 05; 29(11):102358.
Score: 0.233
-
Hemodynamic Consequences of Long-Term Continuous Flow: The Importance of the Right Ventricular-Aortic Valve Interactions. Circ Heart Fail. 2023 10; 16(10):e010713.
Score: 0.221
-
Sex-Based Differences in Hemodynamic Response to Inotropes: A Subanalysis of the DOREMI Trial. JACC Heart Fail. 2023 09; 11(9):1275-1277.
Score: 0.220
-
Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 07 04; 82(1):70-81.
Score: 0.219
-
Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
Score: 0.215
-
The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
Score: 0.210
-
Postoperative tolvaptan use in left ventricular assist device patients: The TOLVAD randomized pilot study. Artif Organs. 2022 Dec; 46(12):2382-2390.
Score: 0.208
-
PREDICT HF: Risk stratification in advanced heart failure using novel hemodynamic parameters. Clin Cardiol. 2024 Jun; 47(6):e24277.
Score: 0.058
-
Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates. JAMA. 2024 02 13; 331(6):500-509.
Score: 0.057
-
Left Ventricular Pressure Ratio Predicts In-Hospital Outcomes in Hospitalized Heart Failure With Reduced Ejection Fraction. J Invasive Cardiol. 2021 07; 33(7):E507-E515.
Score: 0.048